| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 12/25/2013 | EP2173707B1 Pleuromutilin derivatives and their use as antimicrobials |
| 12/25/2013 | CN103476749A Alpha,beta-unsaturated imines |
| 12/25/2013 | CN103467364A Manidipine hydrochloride compound |
| 12/25/2013 | CN103467227A Method for preparing chiral piperidone |
| 12/25/2013 | CN103467225A Method for preparing 1,4-dicarbonyl derivative |
| 12/25/2013 | CN103464207A Rare-earth complex catalyst, and preparation method, application and application method thereof |
| 12/25/2013 | CN102164920B Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof as FAAH enzyme inhibitor |
| 12/25/2013 | CN102020602B Crystal form of lercanidipine hydrochloride and preparation method thereof and crystal form-containing medicinal composition |
| 12/25/2013 | CN101628889B Method for preparing improved donepezil hydrochloride key intermediate |
| 12/25/2013 | CN101048378B Process for synthesis of N-alkoxyamines |
| 12/24/2013 | US8614318 Apoptosis promoters |
| 12/24/2013 | US8614294 Pyrenyloxysulfonic acid fluorescent agents |
| 12/24/2013 | US8614229 Substituted indole derivatives and methods of use thereof |
| 12/24/2013 | CA2600606C Indanes |
| 12/24/2013 | CA2505529C Small technetium-99m and rhenium labeled agents and methods for imaging tissues, organs and tumors |
| 12/19/2013 | WO2013187673A1 Complex vitamin conjugate and antioxidant comprising same |
| 12/19/2013 | WO2013186624A2 Α,β-substituted carbonyl compound, optically active heterocyclic compound derived from same, and synthesis method for same |
| 12/19/2013 | WO2013186153A2 Amidophenoxypropanolamines |
| 12/19/2013 | US20130338358 Method for producing di(arylamino)aryl compound and synthetic intermediate therefor |
| 12/19/2013 | US20130338191 Crystalline freebase forms of a biphenyl compound |
| 12/19/2013 | US20130338163 Vinyl-aryl derivatives for inflammation and immune-related uses |
| 12/19/2013 | US20130338110 Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers |
| 12/18/2013 | EP2672823A1 S1p modulating agents |
| 12/18/2013 | CN103459372A Process for preparing cyclic amine compounds |
| 12/18/2013 | CN103459369A 胍化合物 Guanidine compound |
| 12/18/2013 | CN103459361A 1,5-diphenyl-penta-1,4-dien-3-one compounds |
| 12/18/2013 | CN103456885A Uses of dithiocarbamate compounds |
| 12/18/2013 | CN103450076A Method for preparing clevidipine butyrate |
| 12/18/2013 | CN103450075A Preparation method for optically-active amlodipine |
| 12/17/2013 | US8609852 Thiazolyl mGluR5 antagonists and methods for their use |
| 12/17/2013 | US8609850 Targeted nitroxide agents |
| 12/17/2013 | US8609849 Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
| 12/17/2013 | US8609839 Camphor-derived compounds, method for manufacturing the same, and application thereof |
| 12/17/2013 | US8609736 Telomerase activating compounds and methods of use thereof |
| 12/17/2013 | CA2774250C C-linked hydroxamic acid derivatives useful as antibacterial agents |
| 12/12/2013 | WO2013183904A1 Compound containing benzofluorene for organic electronic device, and organic electronic device and electronic apparatus using same |
| 12/12/2013 | WO2013181741A1 Imino compounds as protecting agents against ultraviolet radiations |
| 12/12/2013 | US20130331578 Novel iminosugars and their applications |
| 12/12/2013 | US20130331396 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 12/12/2013 | US20130327988 Process for the preparation of imides and derivatives thereof and uses |
| 12/12/2013 | CA2875165A1 Imino compounds as protecting agents against ultraviolet radiations |
| 12/11/2013 | EP2671871A1 Novel (aza)benzhydryl ether derivatives, their process of preparation and their use as H4-receptor ligands for therapeutical applications |
| 12/11/2013 | EP2671870A1 Novel (aza)benzhydryl ether derivatives, their process of preparation and their use as H4-receptor ligands for therapeutical applications |
| 12/11/2013 | EP2670734A1 Novel ether linked compounds and improved treatments for cardiac and cardiovascular disease |
| 12/11/2013 | CN103443074A Heterocyclic amine derivatives |
| 12/11/2013 | CN103435538A (R)-3-amino piperidine hydrochloride preparation method |
| 12/11/2013 | CN103435448A High-stereoselectivity method for reducing alkynylamines |
| 12/11/2013 | CN102702052B Novel diamine-containing farnesyl thiosalicylic acid derivative and preparation method and medicinal application thereof |
| 12/10/2013 | US8604207 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| 12/10/2013 | US8604206 Compositions for preventing and/or treating degenerative disorders of the central nervous system |
| 12/10/2013 | US8604205 Cytoskeletal active rho kinase inhibitor compounds, composition and use |
| 12/10/2013 | US8604190 Hetero isonipecotic modulators of vanilloid VR1 receptor |
| 12/10/2013 | US8604062 Process for the preparation of isoxazolyl-methoxy nicotinic acids |
| 12/10/2013 | CA2600904C Trifluoromethylbenzamide derivatives and therapeutic uses thereof |
| 12/05/2013 | WO2013180197A1 NOVEL β-LACTAMASE INHIBITOR AND METHOD FOR PRODUCING SAME |
| 12/05/2013 | US20130324576 Therapeutic compounds |
| 12/05/2013 | US20130324556 Protease Activated Receptor 2 (PAR2) Antagonists |
| 12/05/2013 | US20130324507 Novel (aza)Benzhydryl Ether Derivatives, Their Process of Preparation and Their Use as H4-Receptor Ligands for Therapeutical Applications |
| 12/04/2013 | EP2669281A1 Method for producing di(arylamino)aryl compound, and synthetic intermediate therefor |
| 12/04/2013 | EP2668157A1 Protease activated receptor 2 (par2) antagonists |
| 12/04/2013 | CN1989106B N-羟基酰胺衍生物及其应用 N- hydroxyamide derivatives and their Applications |
| 12/04/2013 | CN103421211A L1,1-dimethylhydarzine stabilizerand the stabilizer composition thereof |
| 12/04/2013 | CN103420901A Preparation method for 1,2-dihydropyridine derivatives |
| 12/04/2013 | CN103420900A Preparation method for halogenated-1,2-dihydropyridine |
| 12/04/2013 | CN103420899A Purification method of clevidipine butyrate |
| 12/04/2013 | CN103420898A Diaryl piperidine derivatives and applications thereof as multiple-target-point antidepressants |
| 12/04/2013 | CN101454004B Pyridone sulfonamides and pyridone sulfamides as mek inhibitors |
| 12/03/2013 | US8598359 Biaryl substituted heterocycle inhibitors of LTA4H for treating inflammation |
| 12/03/2013 | US8598358 Synthetic intermediate of oxazole compound and method for producing the same |
| 12/03/2013 | US8598357 Benzodioxole piperidine compounds |
| 12/03/2013 | US8598356 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| 12/03/2013 | US8598213 Positive allosteric modulators of nicotinic acetylcholine receptor |
| 12/03/2013 | US8598206 Trypsin-like serine protease inhibitors, and their preparation and use |
| 12/03/2013 | US8598181 Modulators of ATP-binding cassette transporters |
| 12/03/2013 | US8598160 Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 12/03/2013 | US8598148 Synthesis of tetracyclines and analogues thereof |
| 12/03/2013 | CA2489590C Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 11/28/2013 | WO2013177269A2 Zirconium-containing precursors for vapor deposition |
| 11/28/2013 | WO2013174736A1 N-[3-(2-carboxyethyl)phenyl]piperidin-1-ylacetamide derivatives and use thereof as activators of soluble guanylate cyclase |
| 11/28/2013 | US20130317028 C5aR ANTAGONISTS |
| 11/28/2013 | US20130316969 Antiviral phosphonate analogs |
| 11/28/2013 | US20130316248 Process for the preparation of compounds containing perfluoroalkanesulfonic acid groups |
| 11/28/2013 | DE102012208530A1 Substituierte Piperidinoacetamide und ihre Verwendung Substituted Piperidinoacetamide and their use |
| 11/27/2013 | CN103408483A Calcium ion channels antagonist manidipine preparation method |
| 11/27/2013 | CN102757382B Purification method of fexofenadine intermediate |
| 11/27/2013 | CN102617391B Resveratrol benzene acrylamide derivative, preparing method and application thereof |
| 11/26/2013 | US8592596 Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound |
| 11/26/2013 | US8592595 Preparation of (N-heterocyclyl) aryl ethers |
| 11/26/2013 | US8592584 Compositions and methods including cell death inducers and procaspase activation |
| 11/26/2013 | US8592498 Method for producing organic compound and organic compound obtained by the method |
| 11/26/2013 | US8592454 Nitrogen-containing heterocyclic compound and use of same |
| 11/26/2013 | US8592453 Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists |
| 11/26/2013 | US8592419 Ceramides and apoptosis-signaling ligand |
| 11/26/2013 | CA2633267C Synthesis of a novel nitroxide antioxidant and methods of use in cosmetic and dermatological compositions |
| 11/21/2013 | WO2013172339A1 Prophylactic agent and/or therapeutic agent for stress urinary incontinence |
| 11/21/2013 | WO2013172239A1 Acid diffusion control agent, radiation-sensitive resin composition, method for forming resist pattern, compound, and method for producing compound |
| 11/21/2013 | WO2013171694A1 Fluorinated bridged spiro[2.4]heptane derivatives as alx receptor agonists |
| 11/21/2013 | US20130310558 Synthesis, structure and use of functionalized naphthalenes |
| 11/21/2013 | US20130310423 Diterpenoid derivatives endowed of biological properties |
| 11/21/2013 | US20130310399 Chemical compounds |